<?xml version="1.0" encoding="UTF-8"?>
<p>The WHO’s Antimicrobial Resistance: Global Report on Surveillance (2014) identified a policy package with broad goals that included strengthened surveillance and laboratory capacity.
 <xref rid="R47" ref-type="bibr">47</xref> However, without adequate funding and accountability measures, such farsighted policies will continue to fall short, especially in the Asia-Pacific region where antimicrobial use is essentially unregulated and strong financial incentives exist to retain the status quo. The WHO Western Pacific Region’s Action Agenda is a step towards tackling these problems, but the agenda includes no plans for effective stewardship.
 <xref rid="R48" ref-type="bibr">48</xref> Lack of funding for cross-disciplinary research was identified as a significant barrier; participants believed that this was exacerbated by the separation of the two major Australian public research funding bodies—the National Health and Medical Research Council (medical) and the Australian Research Council (non-medical). Breaking down traditional medical, veterinary and biological research silos is crucial, with dedicated funding to support cross-disciplinary initiatives.
</p>
